Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 07, 2026 06:00 ET | Source: Serina Therapeutics, Inc.

Serina Therapeutics to Present at the 5th LNP Formulation & Process Development Summit

– Novel lipid nanoparticles entirely built on the POZ Platform that overcome the PEG immunogenicity dilemma – Design & synthesis of novel ionizable POZ lipids to replace current ionizable lipids...
April 07, 2026 06:00 ET | Source: Greenwich LifeSciences, Inc.

Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential

STAFFORD, Texas, April 07, 2026 (GLOBE NEWSWIRE) -- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the "Company"), a clinical-stage biopharmaceutical company focused on its Phase III clinical trial,...
April 07, 2026 04:47 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – transaktioner i forbindelse med aktietilbagekøbsprogram

KØBENHAVN, Danmark, 7. april 2026 – Bavarian Nordic A/S (OMX: BAVA) offentliggør transaktioner under aktietilbagekøbsprogrammet, der blev iværksat den 12. marts 2026, hvorunder selskabet vil...
April 07, 2026 04:47 ET | Source: Bavarian Nordic A/S

Bavarian Nordic – Transactions in Connection with Share Buy-Back Program

COPENHAGEN, Denmark, April 7, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares...
April 07, 2026 04:30 ET | Source: NTG Nordic Transport Group A/S

Transactions in connection with share buy-back program

Company announcement no. 9 - 2607 April 2026 Transactions in connection with share buy-back program On 4 March 2026 NTG Nordic Transport Group (“NTG”) announced a share buy-back program, as...
April 06, 2026 17:59 ET | Source: Renovare Therapeutics, Inc.

Renovare Therapeutics, Inc. Announces Company Launch and Collaboration with CU Boulder Awardee of up to $33.5 Million in ARPA-H Funding to Advance Osteoarthritis Regenerative Therapies

Renovare Therapeutics announces company launch & collaboration with CU Boulder awardee of up to $33.5 million in ARPA-H funding for regenerative therapies
April 06, 2026 16:05 ET | Source: Immuneering Corporation

Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference

Immuneering to Present at the 25th Annual Needham Virtual Healthcare Conference
April 06, 2026 16:01 ET | Source: Dianthus Therapeutics, Inc.

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

NEW YORK and WALTHAM, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company dedicated to developing next-generation therapies...
April 06, 2026 11:43 ET | Source: Biodesix, Inc.

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

LOUISVILLE, Colo., April 06, 2026 (GLOBE NEWSWIRE) -- Biodesix, Inc. (Nasdaq: BDSX), a leading diagnostics solutions company, today announced that the company will present seven abstracts, including...
April 06, 2026 10:00 ET | Source: Adaptin Bio

Adaptin Bio Shares to be Quoted on the OTCQB Under Ticker Symbol APTN

CHARLOTTE, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer therapeutics enabled by...